Dr Ross Triolo, MBBS in Birmingham, AL - Otolaryngology

Dr Ross Triolo, MBBS is a Otolaryngology physician based in Birmingham, Alabama. Dr Ross Triolo is licensed to practice in Alabama (license number L.4594F) and his current practice location is 1802 6th Ave S, Birmingham, Alabama. He can be reached at his office (for appointments etc.) via phone at (205) 934-9713.

NPI number for Dr Ross Triolo is 1831617398 and his current mailing address is 5112 Lane Parke Ct, Mountain Brook, Alabama. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1831617398.

Contact Information

	Dr Ross Triolo, MBBS
	1802 6th Ave S, Birmingham, AL 35233-1932
	(205) 934-9713
	Not Available

Physician's Profile

Full Name	Dr Ross Triolo
Gender	Male
Speciality	Otolaryngology
Location	1802 6th Ave S, Birmingham, Alabama
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1831617398
Provider Enumeration Date: 09/05/2017
Last Update Date: 09/05/2017

Medical Identifiers

Medical identifiers for Dr Ross Triolo such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1831617398	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	L.4594F (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ross Triolo is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Ross Triolo, MBBS 5112 Lane Parke Ct, Mountain Brook, AL 35223-2397 Ph: (205) 706-9370	Dr Ross Triolo, MBBS 1802 6th Ave S, Birmingham, AL 35233-1932 Ph: (205) 934-9713

News Archive

Three 'critical issues' for Global Fund to consider to ensure 'further success'

While the recent report from a High-Level Independent Review Panel of the Global Fund to Fight AIDS, Tuberculosis and Malaria, "and the corresponding decisions of the Board, mark an important step towards the necessary improvements the Global Fund must make to fulfill its vital mandate in the coming decade and beyond," "the report does not provide direction or solutions on certain critical issues that will define the further success and impact of the Global Fund," Richard Feachem, founding executive director of the Global Fund, writes in a Lancet commentary.

MR Solutions offers new continuous PET detectors for better imaging

Traditionally PET imaging has been offered with one, two, three or even four rings of detectors with gaps between the rings. MR Solutions, the independent world leader in preclinical imaging, is now offering continuous PET detection thus avoiding any artifacts caused by the gaps between the rings.

USPTO grants Cenestra Health patent relating to high-purity omega-3 fatty acid formulations

Cenestra Health announced today that the U.S. Patent and Trademark Office has issued a key patent related to the company's high-purity omega-3 fatty acid formulations and their methods of use. U.S. Patent No. 7652068, entitled "Omega-3 Fatty Acid Formulations," covers a unique, high-purity formulation of the omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid).

Children's characteristics may determine response to inhaled corticosteroid therapy for asthma

In a study published online in the Journal of Allergy and Clinical Immunology, researchers at Washington University School of Medicine in St. Louis and five other sites nationwide found that children who showed the most improvement in days without wheezing using an inhaled corticosteroid drug were caucasian boys who had allergies and had a hospitalization or emergency department visit for asthma symptoms in the year prior to the trial.

Parkinson's patients under risk of developing dementia can be identified quickly, say researchers

It may now be possible to identify the first-stage Parkinson's patients who will go on to develop dementia, according to a study conducted at the Institut universitaire de gériatrie de Montréal by Dr. Oury Monchi, PhD, and his postdoctoral student, Dr. Alexandru Hanganu, MD, PhD, both of whom are affiliated with Université de Montréal.

Otolaryngology Doctors in Birmingham, AL

Dr. Grayson K Rodgers, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2700 10th Ave S Ste 502, Birmingham, AL 35205 Phone: 205-933-2951 Fax: 205-933-5893
Dr. Jessica Warren Grayson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011
Brian Kulbersh, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1940 Elmer J Bissell Rd, Birmingham, AL 35243 Phone: 205-638-4949 Fax: 205-638-4982
Dr. Richard Kailean Mchugh, MD, PHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, The Kirklin Clinic, Birmingham, AL 35233 Phone: 205-801-8000
Paul F Castellanos, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600
Dr. David Michael Walters, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1809 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-838-3755 Fax: 205-838-3755
Do Yeon Cho, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999

Dr Ross Triolo, MBBS - Otolaryngology in Birmingham, AL